nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—STAT3—atherosclerosis	0.691	1	CbGaD
Niclosamide—CYP2C9—Rosuvastatin—atherosclerosis	0.0446	0.267	CbGbCtD
Niclosamide—CYP2C9—Simvastatin—atherosclerosis	0.0415	0.248	CbGbCtD
Niclosamide—CYP2C9—Lovastatin—atherosclerosis	0.0406	0.243	CbGbCtD
Niclosamide—CYP2C9—Pravastatin—atherosclerosis	0.0406	0.243	CbGbCtD
Niclosamide—STAT3—endothelium—atherosclerosis	0.00602	0.275	CbGeAlD
Niclosamide—STAT3—blood vessel—atherosclerosis	0.00555	0.254	CbGeAlD
Niclosamide—STAT3—connective tissue—atherosclerosis	0.00285	0.13	CbGeAlD
Niclosamide—STAT3—cardiovascular system—atherosclerosis	0.00248	0.113	CbGeAlD
Niclosamide—STAT3—adipose tissue—atherosclerosis	0.00218	0.0998	CbGeAlD
Niclosamide—STAT3—liver—atherosclerosis	0.00153	0.07	CbGeAlD
Niclosamide—Meclofenamic acid—ALOX5—atherosclerosis	0.00145	0.532	CrCbGaD
Niclosamide—CYP2C9—cardiovascular system—atherosclerosis	0.000556	0.0254	CbGeAlD
Niclosamide—Diflunisal—PTGS2—atherosclerosis	0.000392	0.144	CrCbGaD
Niclosamide—CYP1A2—liver—atherosclerosis	0.000362	0.0166	CbGeAlD
Niclosamide—Meclofenamic acid—PTGS2—atherosclerosis	0.000349	0.129	CrCbGaD
Niclosamide—Diflunisal—ALB—atherosclerosis	0.000349	0.128	CrCbGaD
Niclosamide—CYP2C9—liver—atherosclerosis	0.000344	0.0157	CbGeAlD
Niclosamide—Clonazepam—ALB—atherosclerosis	0.000181	0.0667	CrCbGaD
Niclosamide—STAT3—Disease—APOB—atherosclerosis	3.98e-05	0.00034	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	3.95e-05	0.000338	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL6—atherosclerosis	3.94e-05	0.000337	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD36—atherosclerosis	3.91e-05	0.000334	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—IL6—atherosclerosis	3.88e-05	0.000331	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	3.85e-05	0.000329	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	3.85e-05	0.000329	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCR2—atherosclerosis	3.81e-05	0.000325	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EDNRA—atherosclerosis	3.81e-05	0.000325	CbGpPWpGaD
Niclosamide—STAT3—Disease—LPL—atherosclerosis	3.8e-05	0.000325	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	3.8e-05	0.000325	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CYBA—atherosclerosis	3.79e-05	0.000324	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	3.72e-05	0.000317	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	3.72e-05	0.000317	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PLAT—atherosclerosis	3.71e-05	0.000317	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PARP1—atherosclerosis	3.71e-05	0.000317	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GHRL—atherosclerosis	3.71e-05	0.000317	CbGpPWpGaD
Niclosamide—STAT3—Disease—PRKCG—atherosclerosis	3.7e-05	0.000316	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	3.65e-05	0.000312	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—VEGFA—atherosclerosis	3.62e-05	0.000309	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PDGFB—atherosclerosis	3.61e-05	0.000308	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	3.6e-05	0.000307	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	3.6e-05	0.000307	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	3.58e-05	0.000306	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—AKT1—atherosclerosis	3.58e-05	0.000306	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CRP—atherosclerosis	3.53e-05	0.000301	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MAPK3—atherosclerosis	3.43e-05	0.000293	CbGpPWpGaD
Niclosamide—STAT3—Disease—MTHFR—atherosclerosis	3.42e-05	0.000292	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TLR4—atherosclerosis	3.38e-05	0.000289	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	3.38e-05	0.000289	CbGpPWpGaD
Niclosamide—STAT3—Disease—PDGFB—atherosclerosis	3.33e-05	0.000285	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TGFB1—atherosclerosis	3.32e-05	0.000284	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	3.31e-05	0.000283	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	3.29e-05	0.000281	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KNG1—atherosclerosis	3.26e-05	0.000278	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	3.25e-05	0.000277	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ICAM1—atherosclerosis	3.24e-05	0.000277	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AGTR1—atherosclerosis	3.24e-05	0.000276	CbGpPWpGaD
Niclosamide—STAT3—Disease—APOE—atherosclerosis	3.19e-05	0.000272	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	3.18e-05	0.000271	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	3.18e-05	0.000271	CbGpPWpGaD
Niclosamide—STAT3—Disease—CAV1—atherosclerosis	3.16e-05	0.00027	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PLG—atherosclerosis	3.15e-05	0.000269	CbGpPWpGaD
Niclosamide—STAT3—Disease—APOA1—atherosclerosis	3.15e-05	0.000269	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	3.14e-05	0.000268	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	3.14e-05	0.000268	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	3.14e-05	0.000268	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	3.14e-05	0.000268	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	3.12e-05	0.000266	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TNF—atherosclerosis	3.1e-05	0.000265	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	3.1e-05	0.000265	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	3.06e-05	0.000262	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	3e-05	0.000256	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SOCS3—atherosclerosis	2.99e-05	0.000255	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOS2—atherosclerosis	2.97e-05	0.000254	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP3—atherosclerosis	2.88e-05	0.000246	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	2.87e-05	0.000245	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IGF2—atherosclerosis	2.87e-05	0.000245	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	2.83e-05	0.000242	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APOB—atherosclerosis	2.79e-05	0.000238	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	2.76e-05	0.000236	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EDN1—atherosclerosis	2.74e-05	0.000234	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	2.73e-05	0.000233	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL5—atherosclerosis	2.72e-05	0.000233	CbGpPWpGaD
Niclosamide—STAT3—Disease—INS—atherosclerosis	2.72e-05	0.000232	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	2.68e-05	0.000229	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	2.68e-05	0.000229	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	2.68e-05	0.000229	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	2.68e-05	0.000229	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.67e-05	0.000228	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—LPL—atherosclerosis	2.66e-05	0.000227	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	2.65e-05	0.000226	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PRKCG—atherosclerosis	2.59e-05	0.000221	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PLTP—atherosclerosis	2.57e-05	0.000219	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	2.56e-05	0.000219	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SPP1—atherosclerosis	2.52e-05	0.000215	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6—atherosclerosis	2.5e-05	0.000214	CbGpPWpGaD
Niclosamide—STAT3—Disease—SERPINE1—atherosclerosis	2.5e-05	0.000214	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNG—atherosclerosis	2.47e-05	0.000211	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	2.45e-05	0.00021	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOS3—atherosclerosis	2.39e-05	0.000204	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.38e-05	0.000203	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.37e-05	0.000202	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	2.36e-05	0.000202	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.35e-05	0.000201	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	2.33e-05	0.000199	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PDGFB—atherosclerosis	2.33e-05	0.000199	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—AKT1—atherosclerosis	2.31e-05	0.000197	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.3e-05	0.000196	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.28e-05	0.000195	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AGT—atherosclerosis	2.28e-05	0.000195	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—LEP—atherosclerosis	2.23e-05	0.000191	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APOE—atherosclerosis	2.23e-05	0.000191	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ABCG8—atherosclerosis	2.23e-05	0.00019	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LTA4H—atherosclerosis	2.23e-05	0.00019	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CAV1—atherosclerosis	2.21e-05	0.000189	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APOA1—atherosclerosis	2.21e-05	0.000188	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL1B—atherosclerosis	2.2e-05	0.000188	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.2e-05	0.000188	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PLTP—atherosclerosis	2.2e-05	0.000187	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTGS2—atherosclerosis	2.18e-05	0.000186	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ESR1—atherosclerosis	2.13e-05	0.000182	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—F2—atherosclerosis	2.1e-05	0.00018	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.08e-05	0.000177	CbGpPWpGaD
Niclosamide—STAT3—Immune System—NFKB1—atherosclerosis	2.05e-05	0.000175	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.03e-05	0.000174	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.02e-05	0.000173	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MAPK8—atherosclerosis	2.02e-05	0.000172	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CG—atherosclerosis	2.01e-05	0.000172	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.01e-05	0.000172	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.96e-05	0.000168	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—INS—atherosclerosis	1.91e-05	0.000163	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ABCG8—atherosclerosis	1.9e-05	0.000163	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LTA4H—atherosclerosis	1.9e-05	0.000163	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.88e-05	0.00016	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL2—atherosclerosis	1.88e-05	0.00016	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.85e-05	0.000158	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IGF1—atherosclerosis	1.84e-05	0.000157	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.77e-05	0.000152	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MAPK3—atherosclerosis	1.76e-05	0.00015	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.76e-05	0.00015	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SERPINE1—atherosclerosis	1.75e-05	0.00015	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NOS3—atherosclerosis	1.67e-05	0.000143	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LCAT—atherosclerosis	1.66e-05	0.000141	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—FABP4—atherosclerosis	1.66e-05	0.000141	CbGpPWpGaD
Niclosamide—STAT3—Disease—MAPK3—atherosclerosis	1.63e-05	0.000139	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOA4—atherosclerosis	1.62e-05	0.000139	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.6e-05	0.000136	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.58e-05	0.000135	CbGpPWpGaD
Niclosamide—STAT3—Disease—TGFB1—atherosclerosis	1.58e-05	0.000135	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.52e-05	0.00013	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.5e-05	0.000128	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL8—atherosclerosis	1.48e-05	0.000127	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.48e-05	0.000126	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.45e-05	0.000124	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.42e-05	0.000121	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—FABP4—atherosclerosis	1.41e-05	0.000121	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LCAT—atherosclerosis	1.41e-05	0.000121	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOA2—atherosclerosis	1.4e-05	0.000119	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.4e-05	0.000119	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.4e-05	0.000119	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.4e-05	0.000119	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOA4—atherosclerosis	1.39e-05	0.000119	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.38e-05	0.000118	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.38e-05	0.000118	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.36e-05	0.000116	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP9—atherosclerosis	1.34e-05	0.000115	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LPA—atherosclerosis	1.33e-05	0.000114	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NFKB1—atherosclerosis	1.33e-05	0.000113	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MAPK8—atherosclerosis	1.3e-05	0.000111	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.3e-05	0.000111	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—BGN—atherosclerosis	1.29e-05	0.00011	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6—atherosclerosis	1.29e-05	0.00011	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.28e-05	0.00011	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOA5—atherosclerosis	1.28e-05	0.000109	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.26e-05	0.000108	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.24e-05	0.000106	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.24e-05	0.000106	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.23e-05	0.000105	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.22e-05	0.000104	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.21e-05	0.000103	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.21e-05	0.000103	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VEGFA—atherosclerosis	1.2e-05	0.000103	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.2e-05	0.000103	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.2e-05	0.000102	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.2e-05	0.000102	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOA2—atherosclerosis	1.2e-05	0.000102	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.2e-05	0.000102	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6—atherosclerosis	1.19e-05	0.000102	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.19e-05	0.000102	CbGpPWpGaD
Niclosamide—STAT3—Immune System—AKT1—atherosclerosis	1.19e-05	0.000102	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.18e-05	0.000101	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.18e-05	0.000101	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LPA—atherosclerosis	1.14e-05	9.74e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MAPK3—atherosclerosis	1.14e-05	9.73e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TGFB1—atherosclerosis	1.11e-05	9.44e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—BGN—atherosclerosis	1.1e-05	9.43e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.1e-05	9.38e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKT1—atherosclerosis	1.1e-05	9.37e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.1e-05	9.36e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOA5—atherosclerosis	1.09e-05	9.34e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.07e-05	9.11e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.06e-05	9.07e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.06e-05	9.06e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LIPC—atherosclerosis	1.06e-05	9.05e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOC3—atherosclerosis	1.05e-05	9e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.05e-05	8.99e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LDLR—atherosclerosis	1.05e-05	8.94e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.04e-05	8.89e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.03e-05	8.8e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.03e-05	8.78e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CETP—atherosclerosis	1.02e-05	8.73e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.02e-05	8.68e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SCARB1—atherosclerosis	9.79e-06	8.36e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.54e-06	8.14e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.39e-06	8.02e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HMGCR—atherosclerosis	9.25e-06	7.9e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NAMPT—atherosclerosis	9.12e-06	7.78e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.06e-06	7.74e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LIPC—atherosclerosis	9.06e-06	7.74e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOC3—atherosclerosis	9e-06	7.69e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LDLR—atherosclerosis	8.95e-06	7.64e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CETP—atherosclerosis	8.74e-06	7.46e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SCARB1—atherosclerosis	8.37e-06	7.15e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.34e-06	7.12e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6—atherosclerosis	8.33e-06	7.11e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ABCA1—atherosclerosis	8.24e-06	7.04e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.15e-06	6.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HMGCR—atherosclerosis	7.9e-06	6.75e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKT1—atherosclerosis	7.68e-06	6.56e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.13e-06	6.09e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.07e-06	6.04e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.04e-06	6.02e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOB—atherosclerosis	6.77e-06	5.79e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTM1—atherosclerosis	6.59e-06	5.63e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LPL—atherosclerosis	6.47e-06	5.52e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GPX1—atherosclerosis	6.31e-06	5.39e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CD36—atherosclerosis	6.15e-06	5.25e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.04e-06	5.16e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—MTHFR—atherosclerosis	5.82e-06	4.97e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOB—atherosclerosis	5.79e-06	4.94e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARA—atherosclerosis	5.71e-06	4.88e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTM1—atherosclerosis	5.63e-06	4.81e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AGT—atherosclerosis	5.53e-06	4.73e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LPL—atherosclerosis	5.53e-06	4.72e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOE—atherosclerosis	5.42e-06	4.63e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GPX1—atherosclerosis	5.39e-06	4.61e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CAV1—atherosclerosis	5.37e-06	4.59e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOA1—atherosclerosis	5.36e-06	4.58e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CD36—atherosclerosis	5.25e-06	4.49e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—MTHFR—atherosclerosis	4.98e-06	4.25e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.89e-06	4.18e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARA—atherosclerosis	4.88e-06	4.17e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AGT—atherosclerosis	4.73e-06	4.04e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARG—atherosclerosis	4.72e-06	4.03e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOE—atherosclerosis	4.63e-06	3.96e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—INS—atherosclerosis	4.63e-06	3.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CAV1—atherosclerosis	4.59e-06	3.92e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOA1—atherosclerosis	4.58e-06	3.91e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALB—atherosclerosis	4.25e-06	3.63e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.18e-06	3.57e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NOS3—atherosclerosis	4.06e-06	3.47e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARG—atherosclerosis	4.04e-06	3.45e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—INS—atherosclerosis	3.96e-06	3.38e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.72e-06	3.17e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALB—atherosclerosis	3.63e-06	3.1e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NOS3—atherosclerosis	3.47e-06	2.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.17e-06	2.71e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKT1—atherosclerosis	1.87e-06	1.59e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKT1—atherosclerosis	1.6e-06	1.36e-05	CbGpPWpGaD
